EW
EW clinical trials: Edwards Lifesciences Corp
Every trial on ClinicalTrials.gov where Edwards Lifesciences Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 211
- Trials linked
- 133
- As lead sponsor
- 78
- As collaborator
- 3
- Primary completions as lead sponsor, next 90 days
EW on the catalyst calendar · EW registry changes
- Primary completion Jul 30, 2020ActualNo phase registeredNCT03170349The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System StudyEdwards Lifesciences · Mitral Valve RegurgitationCompletedEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2027Sponsor estimateNo phase registeredNCT04097145Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialEdwards Lifesciences · Tricuspid RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 10, 2027Sponsor estimateNo phase registeredNCT07742839CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance...Edwards Lifesciences · Atrial AppendageNot yet recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2028Sponsor estimateNo phase registeredNCT07363473JOURNEY LVAD: JOURNEY Left Ventricular Assist DeviceJC Medical, Inc., an affiliate of Edwards Lifesciences LLC · Aortic Valve RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2028Sponsor estimateNo phase registeredNCT06455787J-Valve Transfemoral Pivotal StudyJC Medical, Inc., an affiliate of Edwards Lifesciences LLC · Aortic Valve RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2030Sponsor estimateNo phase registeredNCT07684313TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)Edwards Lifesciences · Heart Valve DiseasesRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 18, 2025ActualNo phase registeredNCT05760989TRISCEND JAPAN StudyEdwards Lifesciences · Tricuspid Valve RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 30, 2027Sponsor estimateNo phase registeredNCT07466745Autus Valve Continued Access Study (CAS)Edwards Lifesciences · Congenital Heart DiseaseActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 24, 2026ActualNo phase registeredNCT05006404Autus Valve Pivotal StudyEdwards Lifesciences · Congenital Heart DiseaseActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 10, 2027Sponsor estimateNo phase registeredNCT04153292The ENCIRCLE TrialEdwards Lifesciences · Mitral RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2029Sponsor estimateNo phase registeredNCT05172973ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesEdwards Lifesciences · Aortic Valve InsufficiencyRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2022ActualNo phase registeredNCT03779490Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)Edwards Lifesciences · Tricuspid RegurgitationActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 14, 2022ActualNo phase registeredNCT03130777ALTERRA: SAPIEN 3 THV With the Alterra Adaptive PrestentEdwards Lifesciences · Pulmonary DiseaseActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2030Sponsor estimateNo phase registeredNCT07859709The CLASP III TR CED StudyEdwards Lifesciences · Tricuspid RegurgitationNot yet recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2028Sponsor estimateNo phase registeredNCT07619872KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and PerformanceEdwards Lifesciences · Aortic Valve DiseaseRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT07120048Real World Data Collection on the INSPIRIS RESILIA Aortic ValveEdwards Lifesciences · Aortic Valve DiseaseRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 25, 2025ActualNo phase registeredNCT05378386ALTERRA Post-Approval StudyEdwards Lifesciences · Pulmonary Valve InsufficiencyActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimateNo phase registeredNCT07858799Early Feasibility Study of the Edwards APTURE Transcatheter Shunt SystemEdwards Lifesciences · Heart FailureRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2034Sponsor estimateNo phase registeredNCT05404880INSPIRIS China PMCF StudyEdwards Lifesciences · Aortic Valve ReplacementActive, not recruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimateNo phase registeredNCT03523416Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemEdwards Lifesciences · Heart FailureRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2027Sponsor estimateNo phase registeredNCT06833476TTVR STRONG Under Coverage With Evidence Development (CED) StudyEdwards Lifesciences · Tricuspid RegurgitationRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 16, 2021ActualNo phase registeredNCT03230747SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral RegurgitationEdwards Lifesciences · Mitral RegurgitationCompletedEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2027Sponsor estimateNo phase registeredNCT05172960ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveEdwards Lifesciences · Aortic Stenosis, SevereRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2028Sponsor estimateNo phase registeredNCT04919980TVMR With the INNOVALVE System Trial - Early Feasibility StudyEdwards Lifesciences · Mitral Valve Regurgitation (Degenerative or Functional)RecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2030Sponsor estimateNo phase registeredNCT06569602Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)Edwards Lifesciences · Tricuspid Valve RegurgitationRecruitingEWLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 186 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner